Shanghai Henlius Biotech is in talks with multinational pharmaceutical firms about selling them the rights to an experimental cancer drug.

Shanghai Henlius Biotech is in talks with multinational pharmaceutical firms about selling them the rights to an experimental cancer drug.

Secondo indiscrezioni ci sarebbero anche J&J e Roche fra i gruppi interessati a siglare un accordo per i diritti su un farmaco oncologico sperimentale della biotech cinese